ALEVE Drug Patent Profile
✉ Email this page to a colleague
When do Aleve patents expire, and what generic alternatives are available?
Aleve is a drug marketed by Bayer and Bayer Hlthcare and is included in three NDAs.
The generic ingredient in ALEVE is naproxen sodium; pseudoephedrine hydrochloride. There are forty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the naproxen sodium; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aleve
A generic version of ALEVE was approved as naproxen sodium; pseudoephedrine hydrochloride by PERRIGO on March 17th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALEVE?
- What are the global sales for ALEVE?
- What is Average Wholesale Price for ALEVE?
Summary for ALEVE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 135 |
| Patent Applications: | 3,665 |
| What excipients (inactive ingredients) are in ALEVE? | ALEVE excipients list |
| DailyMed Link: | ALEVE at DailyMed |
Pharmacology for ALEVE
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for ALEVE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer | ALEVE | naproxen sodium | TABLET;ORAL | 020204-002 | Jan 11, 1994 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bayer Hlthcare | ALEVE PM | diphenhydramine hydrochloride; naproxen sodium | TABLET;ORAL | 205352-001 | Jan 17, 2014 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bayer | ALEVE-D SINUS & COLD | naproxen sodium; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021076-001 | Nov 29, 1999 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
